Landscape Capital Management, L.L.C. Allakos Inc. Transaction History

Landscape Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$2.13 - $5.55 $5,425 - $14,135	-2,547 Reduced 10.21%	22,396 $50,000
Q2 2023 Aug 11, 2023	SELL	$3.6 - $5.25 $105,120 - $153,300	-29,200 Reduced 53.93%	24,943 $108,000
Q1 2023 May 10, 2023	BUY	$4.3 - $8.27 $232,814 - $447,762	54,143 New	54,143 $240,000
Q4 2018 Feb 14, 2019	SELL	$31.59 - $62.65 $1.28 Million - $2.55 Million	-40,660 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $1.27 Million - $1.94 Million	40,660 New	40,660 $1.83 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.